NTRP Neurotrope Inc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Neurotrope, Inc. -- NTRP

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky announces it has commenced an investigation of Neurotrope, Inc. (NASDAQ:NTRP) concerning possible violations of federal securities laws.

On February 10, 2017, Home Capital Group disclosed that it had received an enforcement notice from the Ontario Securities Commission (“OSC”). The notice indicated that OSC has reached the preliminary conclusion that Home Capital Group “failed to meet its continuous disclosure obligations” in 2014 and 2015. Then on April 19, 2017, the OSC alleged that CFO Robert Morton and two former CEOs of Home Capital, Gerald Soloway and Martin Reid, had unlawfully misled shareholders by waiting until after the May 2015 filing of its 2014 annual report and its first-quarter 2015 report to disclose the fraudulent activities performed by 45 of its brokers. Indeed, the OSC claims the Company was aware of these activities as early as February 10, 2015 and lied about the cause of the decline in lending. To obtain additional information, go to:

http://zlk.9nl.com/neurotrope-ntrp

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Eduard Korsinsky, Esq.

30 Broad Street - 24th Floor

New York, NY 10004

Tel: (212) 363-7500

Toll Free: (877) 363-5972

Fax: (212) 363-7171

www.zlk.com

EN
08/05/2017

Underlying

NTRPNeurotrope Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurotrope Inc

 PRESS RELEASE
Free
NTRP NEUROTROPE INC

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Laws...

NEW YORK--(BUSINESS WIRE)-- Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Neurotrope, Inc. (NASDAQ:NTRP) securities between January 7, 2016 and April 28, 2017 (the “Class Period”). Investors have until July 17, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit. The Complaint alleges that throughout the Class Period, Defend...

July 14, 2017 1 EN
 PRESS RELEASE
Free
NTRP NEUROTROPE INC

IMMINENT LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourage...

NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Neurotrope, Inc. (“Neurotrope” or the “Company”) (NASDAQ:NTRP) of the July 17, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Neurotrope stock or options between January 7, 2016 and April 28, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/NTRP. There is no cost or obligation to yo...

July 10, 2017 1 EN
 PRESS RELEASE
Free
NTRP NEUROTROPE INC

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Neurotrope, Inc. (Nasdaq: NTRP) (“Neurotrope” or the “Company”) securities during the period between January 7, 2016 and April 28, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until July 17, 2017 to see...

July 8, 2017 1 EN
 PRESS RELEASE
Free
NTRP NEUROTROPE INC

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses...

NEW YORK--(BUSINESS WIRE)-- Pomerantz LLP announces that a class action lawsuit has been filed against Neurotrope, Inc. (“Neurotrope” or the “Company”) (NASDAQ: NTRP) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-04313, is on behalf of a class consisting of investors who purchased or otherwise acquired Neurotrope securities, seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934. ...

July 7, 2017 1 EN
 PRESS RELEASE
Free
NTRP NEUROTROPE INC

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investo...

NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Neurotrope, Inc. (“Neurotrope” or the “Company”) (NASDAQ:NTRP) of the July 17, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Neurotrope stock or options between January 7, 2016 and April 28, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/NTRP. There is no cost or obligation to yo...

June 27, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch